z-logo
open-access-imgOpen Access
Baseline Anti-HBs Antibody Titre in Health Care Workers in a Tertiary Health Care Centre in Faridabad, India
Author(s) -
Sonia Khatter
Publication year - 2021
Publication title -
journal of communicable diseases
Language(s) - English
Resource type - Journals
eISSN - 2581-351X
pISSN - 0019-5138
DOI - 10.24321/0019.5138.202127
Subject(s) - medicine , seroprevalence , titer , vaccination , health care , infection control , hepatitis b , seroconversion , antibody , family medicine , serology , immunology , surgery , economics , economic growth
Healthcare workers (HCWs) are at a high risk of acquiring hepatitis B virus (HBV) infection through occupational exposure which is preventable through hepatitis B vaccination. Aims: Therefore, we aim to establish the seroprevalence of anti-Hepatitis B surface (anti-HBs) antibody in the HCWs in a tertiary care setup to assess the level of protection that workers in these high-risk zones have. Methods and Material: Serum specimens from participants were tested at the Microbiology laboratory of ESIC Medical College & Hospital, Faridabad. Three ml of venous blood was collected aseptically in a vacutainer. The serum anti-HBs titre was detected by Enzyme-linked immunoassay (ELISA) using the Monolisa Anti-HBs PLUS (Bio-Rad) as per manufacturer’s instruction. Results: Of the 218 HCWs included, 145 (66.51%) were vaccinated, and 73 (33.49%) were unvaccinated. HCWs were grouped into five categories which comprise doctors from all disciplines (n=53), nursing staff (n=50), technicians (n=52), nursing orderly (NO) (n=34),and housekeeping (n=29). Among various groups of HCWs, the vaccination rate was highest among doctors (96.23%) than the other groups. While comparing the anti-HBs titre among the unvaccinated HCWs, it has been seen that out of 73 (33.49%) HCWs, majority of the NO (76.47%) were having titre below 10 mIU/ml followed by housekeeping (73.68%), technicians (70.58%), and nursing staff (33.33%). Conclusions: All HCWs should be regularly screened for HBs antigen along with administration of a booster dose and monitoring of anti-HBs titre.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom